twoXAR: 1ST Biotherapeutics and twoXAR Form Co-Development Collaboration to Discover and Develop Treatments for Glioblastoma
1ST Biotherapeutics, Inc., a preclinical-stage biotechnology company focused on neurodegenerative diseases, immuno-oncology, and orphan diseases, and twoXAR, Inc., an artificial intelligence (AI)-driven biopharmaceutical company,
Read full article »
twoXAR is an AI-based platform that offers drug discovery, biomedical informatics, predictive analytics and preclinical validation solutions.
Read more